Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Bee Updated: Current Knowledge on Bee Venom and Bee Envenoming Therapy.

Pucca MB, Cerni FA, Oliveira IS, Jenkins TP, Argemí L, Sørensen CV, Ahmadi S, Barbosa JE, Laustsen AH.

Front Immunol. 2019 Sep 6;10:2090. doi: 10.3389/fimmu.2019.02090. eCollection 2019. Review.

2.

How can monoclonal antibodies be harnessed against neglected tropical diseases and other infectious diseases?

Laustsen AH.

Expert Opin Drug Discov. 2019 Nov;14(11):1103-1112. doi: 10.1080/17460441.2019.1646723. Epub 2019 Jul 31.

PMID:
31364421
3.

History of Envenoming Therapy and Current Perspectives.

Pucca MB, Cerni FA, Janke R, Bermúdez-Méndez E, Ledsgaard L, Barbosa JE, Laustsen AH.

Front Immunol. 2019 Jul 10;10:1598. doi: 10.3389/fimmu.2019.01598. eCollection 2019. Review.

4.

Publisher Correction: In vivo neutralization of dendrotoxin-mediated neurotoxicity of black mamba venom by oligoclonal human IgG antibodies.

Laustsen AH, Karatt-Vellatt A, Masters EW, Arias AS, Pus U, Knudsen C, Oscoz S, Slavny P, Griffiths DT, Luther AM, Leah RA, Lindholm M, Lomonte B, Gutiérrez JM, McCafferty J.

Nat Commun. 2018 Nov 20;9(1):4957. doi: 10.1038/s41467-018-07480-8.

5.

In vivo neutralization of dendrotoxin-mediated neurotoxicity of black mamba venom by oligoclonal human IgG antibodies.

Laustsen AH, Karatt-Vellatt A, Masters EW, Arias AS, Pus U, Knudsen C, Oscoz S, Slavny P, Griffiths DT, Luther AM, Leah RA, Lindholm M, Lomonte B, Gutiérrez JM, McCafferty J.

Nat Commun. 2018 Oct 2;9(1):3928. doi: 10.1038/s41467-018-06086-4. Erratum in: Nat Commun. 2018 Nov 20;9(1):4957.

6.

Recent Advances in Next Generation Snakebite Antivenoms.

Knudsen C, Laustsen AH.

Trop Med Infect Dis. 2018 Apr 15;3(2). pii: E42. doi: 10.3390/tropicalmed3020042. Review.

7.

Snake Venomics Display: An online toolbox for visualization of snake venomics data.

Dam SH, Friis RUW, Petersen SD, Martos-Esteban A, Laustsen AH.

Toxicon. 2018 Sep 15;152:60-64. doi: 10.1016/j.toxicon.2018.07.019. Epub 2018 Jul 25.

PMID:
30053438
8.

Basics of Antibody Phage Display Technology.

Ledsgaard L, Kilstrup M, Karatt-Vellatt A, McCafferty J, Laustsen AH.

Toxins (Basel). 2018 Jun 9;10(6). pii: E236. doi: 10.3390/toxins10060236. Review.

9.

Toxin-centric development approach for next-generation antivenoms.

Laustsen AH.

Toxicon. 2018 Aug;150:195-197. doi: 10.1016/j.toxicon.2018.05.021. Epub 2018 May 29. No abstract available.

PMID:
29857088
10.

Pros and cons of different therapeutic antibody formats for recombinant antivenom development.

Laustsen AH, María Gutiérrez J, Knudsen C, Johansen KH, Bermúdez-Méndez E, Cerni FA, Jürgensen JA, Ledsgaard L, Martos-Esteban A, Øhlenschlæger M, Pus U, Andersen MR, Lomonte B, Engmark M, Pucca MB.

Toxicon. 2018 May;146:151-175. doi: 10.1016/j.toxicon.2018.03.004. Epub 2018 Mar 10. Review.

11.

High-density peptide microarray exploration of the antibody response in a rabbit immunized with a neurotoxic venom fraction.

Engmark M, Jespersen MC, Lomonte B, Lund O, Laustsen AH.

Toxicon. 2017 Nov;138:151-158. doi: 10.1016/j.toxicon.2017.08.028. Epub 2017 Sep 1.

PMID:
28867663
12.

Cross-recognition of a pit viper (Crotalinae) polyspecific antivenom explored through high-density peptide microarray epitope mapping.

Engmark M, Lomonte B, Gutiérrez JM, Laustsen AH, De Masi F, Andersen MR, Lund O.

PLoS Negl Trop Dis. 2017 Jul 14;11(7):e0005768. doi: 10.1371/journal.pntd.0005768. eCollection 2017 Jul.

13.

Guiding recombinant antivenom development by omics technologies.

Laustsen AH.

N Biotechnol. 2018 Oct 25;45:19-27. doi: 10.1016/j.nbt.2017.05.005. Epub 2017 May 24. Review.

PMID:
28552814
14.

Recombinant snakebite antivenoms: A cost-competitive solution to a neglected tropical disease?

Laustsen AH, Johansen KH, Engmark M, Andersen MR.

PLoS Negl Trop Dis. 2017 Feb 3;11(2):e0005361. doi: 10.1371/journal.pntd.0005361. eCollection 2017 Feb.

15.

Exploration of immunoglobulin transcriptomes from mice immunized with three-finger toxins and phospholipases A2 from the Central American coral snake, Micrurus nigrocinctus.

Laustsen AH, Engmark M, Clouser C, Timberlake S, Vigneault F, Gutiérrez JM, Lomonte B.

PeerJ. 2017 Jan 24;5:e2924. doi: 10.7717/peerj.2924. eCollection 2017.

16.

High-throughput immuno-profiling of mamba (Dendroaspis) venom toxin epitopes using high-density peptide microarrays.

Engmark M, Andersen MR, Laustsen AH, Patel J, Sullivan E, de Masi F, Hansen CS, Kringelum JV, Lomonte B, Gutiérrez JM, Lund O.

Sci Rep. 2016 Nov 8;6:36629. doi: 10.1038/srep36629.

17.

Exploring the venom of the forest cobra snake: Toxicovenomics and antivenom profiling of Naja melanoleuca.

Lauridsen LP, Laustsen AH, Lomonte B, Gutiérrez JM.

J Proteomics. 2017 Jan 6;150:98-108. doi: 10.1016/j.jprot.2016.08.024. Epub 2016 Sep 1.

PMID:
27593527
18.

Snakebites: costing recombinant antivenoms.

Laustsen AH.

Nature. 2016 Oct 6;538(7623):41. doi: 10.1038/538041e. No abstract available.

PMID:
27708295
19.

From Fangs to Pharmacology: The Future of Snakebite Envenoming Therapy.

Laustsen AH, Engmark M, Milbo C, Johannesen J, Lomonte B, Gutiérrez JM, Lohse B.

Curr Pharm Des. 2016;22(34):5270-5293. Review.

PMID:
27339430
20.

Toxicovenomics and antivenom profiling of the Eastern green mamba snake (Dendroaspis angusticeps).

Lauridsen LP, Laustsen AH, Lomonte B, Gutiérrez JM.

J Proteomics. 2016 Mar 16;136:248-61. doi: 10.1016/j.jprot.2016.02.003. Epub 2016 Feb 12.

PMID:
26877184

Supplemental Content

Loading ...
Support Center